Company profile
ADmit Therapeutics
Identification of an early Alzheimer's disease will accelerate the identification of curative drugs.
- Industry
- Biotechnology Research
- Employees
- 14
- Headquarters
- Sant Feliu de Llobregat, Barcelona
- Founded
- 2017
- LinkedIn followers
- 3,032
- Office locations
- 1
ADmit Therapeutics company summary
ADmit Therapeutics is a company in the Biotechnology Research industry, headquartered in Sant Feliu de Llobregat, Barcelona, founded in 2017. On LinkedIn the company has around 14 employees and 3,032 followers. Its listed specialties include Epigenetics, Next Generation Sequencing, Dementia, Alzheimer's disease.
What technology does ADmit Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ADmit Therapeutics
ADmit Therapeutics is a biotech company focused on the commercialization of the MAP-AD® Test, an AI-powered prognostic test for Alzheimer’s disease with CE-IVDR certification. The company operates a CAP-accredited, CLIA-certified laboratory to offer the MAP-AD Test as an LDT in the US
Specialties
Where is ADmit Therapeutics located?
ADmit Therapeutics lists 1 location.
Compare companies similar to ADmit Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ADmit Therapeutics admit-therapeutics.com | Biotechnology Research | 14 | 2017 | Sant Feliu de Llobregat, Barcelona |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ADmit Therapeutics
What does ADmit Therapeutics do?
ADmit Therapeutics is a biotech company focused on the commercialization of the MAP-AD® Test, an AI-powered prognostic test for Alzheimer’s disease with CE-IVDR certification. The company operates a CAP-accredited, CLIA-certified laboratory to offer the MAP-AD Test as an LDT in the US
How many employees does ADmit Therapeutics have?
ADmit Therapeutics has around 14 employees on LinkedIn.
Where is ADmit Therapeutics headquartered?
ADmit Therapeutics is headquartered in Sant Feliu de Llobregat, Barcelona.
When was ADmit Therapeutics founded?
ADmit Therapeutics was founded in 2017.
Build a lead list from companies like ADmit Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.